Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Vetmedin 2.5 mg - V/NRP/00/1126 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: capsules for oral use
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Klocke Pharma Service GmbH, Vācija
Date of authorisation/renewal: 15-Feb-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 31072019LI (31-Jul-2019)
Labelling text: [PDF] 31072019M (31-Jul-2019)
Summary of product characteristics: [PDF] 31072019ZA (31-Jul-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/00/1126-01 2,5 mg 1 Polietilēna pudelīte, 100 tablete -
Vetmedin 5 mg - V/NRP/09/0003 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: capsules for oral use
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Klocke Pharma Service GmbH, Vācija
Date of authorisation/renewal: 15-Feb-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 31072019LI (31-Jul-2019)
Labelling text: [PDF] 31072019M (31-Jul-2019)
Summary of product characteristics: [PDF] 31072019ZA (31-Jul-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/09/0003-01 5 mg 1 Polietilēna pudele, 100 kapsulas -
Feligen CRP/R - V/NRP/08/1594 Virbac S.A., Francija QI06AD04 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Feline rhinotracheitis virus,Inactivated Rabies virus,Live attenuated feline panleucopenia virus,Live feline calicivirus, strain F9
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 30-May-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1594-01 10 Stikla flakons, 1 deva -
V/NRP/08/1594-02 50 Stikla flakons, 1 deva -
Cevac IBD 2512 L - V/MRP/13/0005 Ceva Sante Animale., Francija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oral suspension
International name (active substance): Avian infectious bursal disease virus Winterfield 2512, G-61 strain
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Apr-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 270417LI (28-Apr-2017)
Labelling text: [PDF] 270417M (28-Apr-2017)
Summary of product characteristics: [PDF] 270417ZA (28-Apr-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0005-01 20 Stikla flakons, 1000 deva -
V/MRP/13/0005-02 20 Stikla flakons, 2500 deva -
V/MRP/13/0005-03 20 Stikla flakons, 5000 deva -
Vetemex 10 mg/ml V/SRP/23/0013 CP-Pharma Handelsgesellschaft GmbH, Vācija QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 28-Mar-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Mar-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Mar-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/23/0013-01 1 Stikla flakons, 10 ml -
V/SRP/23/0013-02 1 Stikla flakons, 20 ml [PDF] [PDF]
V/SRP/23/0013-03 1 Stikla flakons, 25 ml -
V/SRP/23/0013-04 1 Stikla flakons, 50 ml -
Presedine 10 mg/ml V/DCP/23/0017 Alfasan Nederland BV, Nīderlande QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0017-01 10 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/23/0017-02 10 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/23/0017-03 10 mg/ml 1 Stikla flakons, 20 ml -
Spirovet 600000 IU/ml V/MRP/12/0056 Ceva Sante Animale', Francija QJ01FA02 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Spiramycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0056-01 600000 IU/ml 1 Stikla flakons, 50 ml -
V/MRP/12/0056-02 600000 IU/ml 1 Stikla flakons, 100 ml -
V/MRP/12/0056-03 600000 IU/ml 1 Stikla flakons, 250 ml -
V/MRP/12/0056-04 600000 IU/ml 1 Plastmasas pudele, 50 ml -
V/MRP/12/0056-05 600000 IU/ml 1 Plastmasas pudele, 100 ml -
V/MRP/12/0056-06 600000 IU/ml 1 Plastmasas pudele, 250 ml -
Prinocate 40 mg/4 mg - V/DCP/20/0005 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 ferrets; small cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0005-01 40/4 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-02 40/4 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-03 40/4 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-04 40/4 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-05 40/4 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-06 40/4 48 Polipropilēna pipete, 0,4 ml -
Prinocate 80 mg/8 mg - V/DCP/20/0006 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0006-01 80/8 mg 1 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-02 80/8 mg 3 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-03 80/8 mg 4 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-04 80/8 mg 6 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-05 80/8 mg 24 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-06 80/8 mg 48 Polipropilēna pipete, 0,8 ml -
Prinocate 40 mg/10 mg - V/DCP/20/0007 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0007-01 40/10 mg 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-02 40/10 mg 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-03 40/10 mg 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-04 40/10 mg 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-05 40/10 mg 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-06 40/10 mg 48 Polipropilēna pipete, 0,4 ml -
Prinocate 100 mg/25 mg - V/DCP/20/0008 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0008-01 100/25 mg 1 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-02 100/25 mg 3 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-03 100/25 mg 4 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-04 100/25 mg 6 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-05 100/25 mg 24 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-06 100/25 mg 48 Polipropilēna pipete, 1 ml -
Prinocate 250 mg/62,5 mg - V/DCP/20/0009 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0009-01 250/62,5 mg 1 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-02 250/62,5 mg 3 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-03 250/62,5 mg 4 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-04 250/62,5 mg 6 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-05 250/62,5 mg 24 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-06 250/62,5 mg 48 Polipropilēna pipete, 2,5 ml -
Prinocate 400 mg/100 mg - V/DCP/20/0010 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0010-01 400/100 mg 1 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-02 400/100 mg 3 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-03 400/100 mg 4 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-04 400/100 mg 6 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-05 400/100 mg 24 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-06 400/100 mg 48 Polipropilēna pipete, 4 ml -
Cepedol Vet 20 mg V/DCP/24/0018 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0018-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Cepedol Vet 50 mg V/DCP/24/0019 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0019-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Mexxam Vet 15 mg/ml V/DCP/23/0001 Alfasan Nederland BV, Nīderlande QM01AC06 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande;Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 23-Jan-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (23-Jan-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0001-01 1 Polietilēna pudelīte, 125 ml -
V/DCP/23/0001-02 1 Polietilēna pudelīte, 336 ml -
Cardisan 1.25 mg V/DCP/22/0050 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0050-01 1,25 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-02 1,25 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-03 1,25 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-04 1,25 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-05 1,25 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 2.5 mg V/DCP/22/0051 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0051-01 2,5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-02 2,5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-03 2,5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-04 2,5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-05 2,5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 5 mg V/DCP/22/0052 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0052-01 5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-02 5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-03 5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-04 5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-05 5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 10 mg V/DCP/22/0053 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0053-01 10 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-02 10 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-03 10 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-04 10 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-05 10 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy